Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March ...

The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure ...

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...

Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ... The move raises privacy concerns as the drugmaker takes control of the genetic ...

The FTSE 100 , US markets and European stocks floundered on Monday, despite a new deal struck between the EU and UK, as ...

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

Through the deal, Regeneron aims to bolster its capabilities in genomics-driven drug discovery by integrating 23andMe's trove of over 15 million customer DNA profiles, collected via its popular direct ...

Japanese prime minister Shigeru Ishiba said his country’s financial condition was worse than Greece’s as he rejected calls ...

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...